牛叉诊股

[{"date":"2026.01.06","stock":"0.40","trade":"0.58","ind":"1.40"},{"date":"2026.01.05","stock":"2.87","trade":"2.21","ind":"2.24"},{"date":"2025.12.31","stock":"-0.18","trade":"-0.42","ind":"-0.58"},{"date":"2025.12.30","stock":"-0.35","trade":"-0.80","ind":"0.49"},{"date":"2025.12.29","stock":"-1.04","trade":"-1.56","ind":"-0.49"},{"date":"2025.12.26","stock":"-0.17","trade":"-0.59","ind":"0.54"},{"date":"2025.12.25","stock":"0.35","trade":"0.49","ind":"0.33"},{"date":"2025.12.24","stock":"0.00","trade":"0.14","ind":"0.88"},{"date":"2025.12.23","stock":"-0.69","trade":"-1.13","ind":"0.27"},{"date":"2025.12.22","stock":"-0.74","trade":"-0.02","ind":"1.47"},{"date":"2025.12.19","stock":"1.15","trade":"1.30","ind":"0.66"},{"date":"2025.12.18","stock":"-0.34","trade":"0.74","ind":"-1.29"},{"date":"2025.12.17","stock":"1.99","trade":"0.75","ind":"2.40"},{"date":"2025.12.16","stock":"-2.73","trade":"-1.92","ind":"-1.51"},{"date":"2025.12.15","stock":"0.40","trade":"-0.38","ind":"-1.10"},{"date":"2025.12.12","stock":"-0.96","trade":"-0.79","ind":"0.84"},{"date":"2025.12.11","stock":"0.28","trade":"-1.22","ind":"-1.27"},{"date":"2025.12.10","stock":"0.23","trade":"-0.11","ind":"0.29"},{"date":"2025.12.09","stock":"-2.12","trade":"-1.56","ind":"-0.39"},{"date":"2025.12.08","stock":"-1.32","trade":"-0.39","ind":"1.39"},{"date":"2025.12.05","stock":"0.06","trade":"-0.36","ind":"1.08"}]

以岭药业,深证成指,中药指数

压力支撑

该股压力位为17.60元，支撑位为17.48元。

[{"text":"\u538b\u529b\u4f4d","value":"17.60","date":1767628800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"17.48","date":1767628800,"color":"0x0b52a1"}]

多空趋势

空头行情中，目前反弹趋势有所减缓，投资者可适当关注。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：4.0资金面打败了39%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力没有控盘。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

中药行业，近5日资金总体无进出。

更新时间：01月06日 20:32

机构今日流向(万元)	5.55	机构5日流向(万元)	-738.84
机构10日流向(万元)	-3113.73	机构20日流向(万元)	-13153.99

机构持仓

2025-06-30 与 2024-12-31 相比，主力机构持仓量减少224.48万股，其中基金净减仓38家，主力净增仓84家，暂未发现中长期投资价值。

截止2025-06-30，共232家主力机构（基金230家，一般法人2家），持仓量总计59058.31万股，占流通A股42.89%
其中，基金持仓与2024-12-31相比：
增仓：26家，增持 201.03万股
减仓：64家，减持 217.36万股
新出现在主力名单中：132家，持有1275.23万股
从主力名单中消失：48家，原持有377.19万股

消息面诊股

诊断结果：5.5消息面打败了22%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	高管变动	取消监事会	2025-12-22
一般消息	重大事项	公司股东股份解押	2025-12-20
一般消息	股东大会	临时股东大会	2025-12-06
一般消息	重大事项	公司股东股份解押	2025-10-18
利好	分红转增	10派3元(含税)	2025-08-28
一般消息	分红转增	不分配不转增	2025-04-29
一般消息	重大事项	关联交易	2025-04-29
一般消息	重大事项	公司股东股份解押	2025-02-25

一年消息统计

	所有消息	重大消息	非重大消息
利好	1条	0条	1条
利空	0条	0条	0条

行业面诊股

诊断结果：6.0行业面打败了68%的股票中药行业最新资金流向

近10日来该行业走势不明显，跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，跑输大盘。

[{"date":"2026.01.06","price":"1.40","value":"-0.80"},{"date":"2026.01.05","price":"2.24","value":"-1.56"},{"date":"2025.12.31","price":"-0.58","value":"-0.59"},{"date":"2025.12.30","price":"0.49","value":"0.49"},{"date":"2025.12.29","price":"-0.49","value":"0.14"},{"date":"2025.12.26","price":"0.54","value":"-1.13"},{"date":"2025.12.25","price":"0.33","value":"-0.02"},{"date":"2025.12.24","price":"0.88","value":"1.30"},{"date":"2025.12.23","price":"0.27","value":"0.74"},{"date":"2025.12.22","price":"1.47","value":"0.75"},{"date":"2025.12.19","price":"0.66","value":"-1.92"},{"date":"2025.12.18","price":"-1.29","value":"-0.38"},{"date":"2025.12.17","price":"2.40","value":"-0.79"},{"date":"2025.12.16","price":"-1.51","value":"-1.22"},{"date":"2025.12.15","price":"-1.10","value":"-0.11"},{"date":"2025.12.12","price":"0.84","value":"-1.56"},{"date":"2025.12.11","price":"-1.27","value":"-0.39"},{"date":"2025.12.10","price":"0.29","value":"-0.36"},{"date":"2025.12.09","price":"-0.39","value":"-1.07"},{"date":"2025.12.08","price":"1.39","value":"1.34"},{"date":"2025.12.05","price":"1.08","value":"-0.75"}]

深证成指,中药行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	维康药业	17.21%	12.86%	5.5分
2	万邦德	12.96%	2.41%	5.8分
3	吉林敖东	7.08%	5.30%	5.9分
4	东阿阿胶	6.01%	3.22%	6.5分
5	仁和药业	3.31%	8.13%	6.0分
6	云南白药	2.61%	1.22%	6.8分
7	华润三九	1.84%	0.00%	6.1分
8	古汉医药	1.65%	5.86%	5.5分
9	片仔癀	1.54%	0.79%	5.4分
10	天目药业	1.51%	2.40%	6.1分
11	葵花药业	0.94%	0.47%	4.5分
12	马应龙	0.32%	0.39%	4.8分
13	白云山	0.08%	0.35%	5.8分
14	沃华医药	0.00%	10.19%	6.4分
15	达仁堂	-0.13%	-2.17%	5.6分
16	江中药业	-0.17%	-2.75%	4.9分
17	天士力	-0.52%	-0.13%	6.0分
18	方盛制药	-1.23%	-1.75%	6.4分
19	嘉应制药	-1.52%	-2.72%	4.1分
20	佛慈制药	-1.57%	0.00%	4.9分
21	羚锐制药	-2.04%	2.91%	6.3分
22	奇正藏药	-2.06%	0.41%	5.2分
23	益佰制药	-2.12%	0.48%	4.5分
24	康美药业	-2.51%	0.00%	5.8分
25	九芝堂	-2.70%	1.12%	5.7分
26	佐力药业	-2.70%	-1.13%	4.5分
27	三力制药	-2.71%	-0.76%	5.3分
28	ST香雪	-2.77%	-4.00%	5.2分
29	太极集团	-2.87%	2.48%	5.7分
30	广誉远	-2.94%	0.87%	5.6分
31	同仁堂	-3.02%	0.50%	5.2分
32	恩威医药	-3.03%	4.38%	6.0分
33	昆药集团	-3.04%	0.79%	5.4分
34	康惠股份	-3.07%	3.93%	4.4分
35	以岭药业	-3.08%	1.67%	5.8分
36	华森制药	-3.12%	-0.20%	5.5分
37	济川药业	-3.18%	-0.90%	5.6分
38	-	-3.19%	-2.26%	分
39	亚宝药业	-3.22%	0.61%	5.4分
40	寿仙谷	-3.58%	-0.67%	5.0分
41	新天药业	-3.71%	0.60%	5.0分
42	康缘药业	-4.27%	2.03%	5.8分
43	千金药业	-4.28%	0.10%	4.8分
44	康恩贝	-4.66%	-0.22%	4.8分
45	上海凯宝	-4.81%	0.49%	4.8分
46	汉森制药	-4.91%	-0.90%	4.1分
47	红日药业	-4.99%	0.56%	4.9分
48	桂林三金	-5.02%	0.00%	5.0分
49	中恒集团	-6.33%	1.08%	4.2分
50	-	-6.40%	-4.26%	分
51	众生药业	-6.63%	4.59%	5.7分
52	振东制药	-6.86%	2.86%	5.1分
53	精华制药	-7.50%	0.41%	5.1分
54	金花股份	-7.61%	-1.42%	4.1分
55	健民集团	-7.62%	-3.62%	4.9分
56	步长制药	-7.89%	-5.21%	5.5分
57	陇神戎发	-7.91%	1.26%	4.2分
58	新光药业	-8.03%	0.85%	4.5分
59	华神科技	-9.05%	-1.75%	4.3分
60	盘龙药业	-9.17%	0.13%	4.7分
61	珍宝岛	-9.71%	-5.34%	4.4分
62	益盛药业	-12.77%	0.13%	4.0分
63	特一药业	-12.95%	0.35%	5.2分
64	信邦制药	-16.03%	0.30%	4.9分
65	太龙药业	-16.04%	-0.59%	4.7分
66	ST葫芦娃	-16.36%	-13.61%	4.7分
67	ST百灵	-17.05%	-5.66%	4.0分
68	粤万年青	-24.21%	0.66%	4.2分
69	*ST长药	-57.69%	-40.14%	4.8分

<上一页 1 2 3 4 5...12 下一页>

行业评级

最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

综合评级

研究机构	评级日期	最新评级	上次评级
中信证券	2012-09-10	增持	增持
招商证券	2012-09-08	增持	增持
航天证券	2012-09-06	增持	-
中银国际	2012-09-05	增持	-
齐鲁证券	2012-09-05	增持	-

基本面诊股

诊断结果：7.3基本面打败了93%的股票连续3年业绩增长30%的公司

该公司运营状况良好，多数机构认为该股长期投资价值较高。

个股深一度

潜在高分红能力：弱（82.5分）

基本面得分最高的股票

[ 截止日期：2025-09-30 ]公司经营

盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 14/109 ， 24/109。

[{"date":"2025-09-30","value":"9.56","vol":"4.74"},{"date":"2025-06-30","value":"6.34","vol":"3.98"},{"date":"2025-03-31","value":"3.14","vol":"2.21"},{"date":"2024-12-31","value":"-6.69","vol":"4.80"},{"date":"2024-09-30","value":"4.83","vol":"2.91"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
净资产收益率(%)	9.56	6.34	3.14	-6.69	4.83
行业(%)	4.74	3.98	2.21	4.80	2.91

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"60.53","vol":"52.31"},{"date":"2025-06-30","value":"59.48","vol":"52.86"},{"date":"2025-03-31","value":"53.82","vol":"53.38"},{"date":"2024-12-31","value":"50.19","vol":"52.74"},{"date":"2024-09-30","value":"53.39","vol":"53.11"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
销售毛利率(%)	60.53	59.48	53.82	50.19	53.39
行业(%)	52.31	52.86	53.38	52.74	53.11

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 39/109 ， 11/109。

[{"date":"2025-09-30","value":"-7.82","vol":"-7.31"},{"date":"2025-06-30","value":"-12.26","vol":"-7.31"},{"date":"2025-03-31","value":"-6.52","vol":"-7.18"},{"date":"2024-12-31","value":"-36.88","vol":"-7.35"},{"date":"2024-09-30","value":"-25.76","vol":"-5.11"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
营业收入同比增长率(%)	-7.82	-12.26	-6.52	-36.88	-25.76
行业(%)	-7.31	-7.31	-7.18	-7.35	-5.11

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"80.33","vol":"-2.54"},{"date":"2025-06-30","value":"26.03","vol":"2.98"},{"date":"2025-03-31","value":"7.25","vol":"-37.19"},{"date":"2024-12-31","value":"-153.57","vol":"-146.29"},{"date":"2024-09-30","value":"-68.45","vol":"61.78"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
净利润同比增长率(%)	80.33	26.03	7.25	-153.57	-68.45
行业(%)	-2.54	2.98	-37.19	-146.29	61.78

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 20/109 ， 40/109。

[{"date":"2025-09-30","value":"0.43","vol":"0.35"},{"date":"2025-06-30","value":"0.30","vol":"0.24"},{"date":"2025-03-31","value":"0.17","vol":"0.12"},{"date":"2024-12-31","value":"0.43","vol":"0.50"},{"date":"2024-09-30","value":"0.38","vol":"0.37"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
总资产周转率(次)	0.43	0.30	0.17	0.43	0.38
行业(次)	0.35	0.24	0.12	0.50	0.37

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"1.35","vol":"1.73"},{"date":"2025-06-30","value":"1.02","vol":"1.18"},{"date":"2025-03-31","value":"0.70","vol":"0.61"},{"date":"2024-12-31","value":"1.54","vol":"2.42"},{"date":"2024-09-30","value":"1.35","vol":"1.81"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
存货增长率(次)	1.35	1.02	0.70	1.54	1.35
行业(次)	1.73	1.18	0.61	2.42	1.81

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2025-09-30","value":"24.42","vol":"9.48"},{"date":"2025-06-30","value":"29.25","vol":"20.05"},{"date":"2025-03-31","value":"14.42","vol":"-0.23"},{"date":"2024-12-31","value":"195.79","vol":"15.64"},{"date":"2024-09-30","value":"3.32","vol":"5.86"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
现金流量净额/营业收入	24.42	29.25	14.42	195.79	3.32
行业	9.48	20.05	-0.23	15.64	5.86

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.29","vol":"1.02"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.47","vol":"1.45"},{"date":"2024-09-30","value":"","vol":"0.00"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
资本支出／折旧和摊销	-	0.29	-	0.47	-
行业	0.00	1.02	0.00	1.45	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 8/109 ， 13/109。

[{"date":"2025-09-30","value":"1.85","vol":"3.05"},{"date":"2025-06-30","value":"2.05","vol":"2.90"},{"date":"2025-03-31","value":"1.80","vol":"2.99"},{"date":"2024-12-31","value":"1.66","vol":"2.88"},{"date":"2024-09-30","value":"1.57","vol":"3.25"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
流动比率	1.85	2.05	1.80	1.66	1.57
行业	3.05	2.90	2.99	2.88	3.25

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"1.24","vol":"2.21"},{"date":"2025-06-30","value":"1.41","vol":"2.13"},{"date":"2025-03-31","value":"1.22","vol":"2.22"},{"date":"2024-12-31","value":"0.91","vol":"2.11"},{"date":"2024-09-30","value":"1.02","vol":"2.43"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
速动比率	1.24	1.41	1.22	0.91	1.02
行业	2.21	2.13	2.22	2.11	2.43

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 38/109 ， 41/109。

[{"date":"2025-09-30","value":"24.77","vol":"33.12"},{"date":"2025-06-30","value":"21.81","vol":"33.87"},{"date":"2025-03-31","value":"23.13","vol":"33.29"},{"date":"2024-12-31","value":"23.40","vol":"34.05"},{"date":"2024-09-30","value":"30.87","vol":"32.87"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
资产负债率(%)	24.77	21.81	23.13	23.40	30.87
行业(%)	33.12	33.87	33.29	34.05	32.87

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"0.33","vol":"0.75"},{"date":"2025-06-30","value":"0.28","vol":"0.74"},{"date":"2025-03-31","value":"0.30","vol":"0.72"},{"date":"2024-12-31","value":"0.30","vol":"0.75"},{"date":"2024-09-30","value":"0.45","vol":"3.20"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
产权比率 (%)	0.33	0.28	0.30	0.30	0.45
行业(%)	0.75	0.74	0.72	0.75	3.20

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。

研究机构	评级日期	最新评级	上次评级
国投证券	2025-11-21	买入	买入
中信建投证券	2025-11-05	买入
光大证券	2025-10-31	买入
浙商证券	2025-10-29	买入
华泰证券	2025-10-28	买入

机构预测

机构预测该股2025年每股收益与前一年相同，长期投资价值一般。

[{"date":"2021","yellowRectValue":"13.44","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"23.63","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"13.52","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-7.25","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"12.86","blueLineValue":"0.77","type":"YC"}]

[以岭药业]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]